Federal Reserve Economic Data

Table Data - Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: Interest Expense

Title Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: Interest Expense
Series ID QFR105385USNO
Source U.S. Census Bureau
Release Quarterly Financial Report
Seasonal Adjustment Not Seasonally Adjusted
Frequency Quarterly
Units Millions of Dollars
Date Range 2000-10-01 to 2024-04-01
Last Updated 2024-09-10 9:09 AM CDT
Notes
DATE VALUE
2000-10-01 1583
2001-01-01 1236
2001-04-01 1265
2001-07-01 901
2001-10-01 1092
2002-01-01 1077
2002-04-01 953
2002-07-01 1004
2002-10-01 930
2003-01-01 910
2003-04-01 932
2003-07-01 940
2003-10-01 944
2004-01-01 909
2004-04-01 991
2004-07-01 889
2004-10-01 1040
2005-01-01 1143
2005-04-01 1013
2005-07-01 1239
2005-10-01 1571
2006-01-01 1175
2006-04-01 1038
2006-07-01 1105
2006-10-01 2000
2007-01-01 1880
2007-04-01 1814
2007-07-01 1994
2007-10-01 2399
2008-01-01 2381
2008-04-01 2313
2008-07-01 2327
2008-10-01 2381
2009-01-01 2215
2009-04-01 3035
2009-07-01 3214
2009-10-01 2988
2010-01-01 3246
2010-04-01 3265
2010-07-01 3324
2010-10-01 2947
2011-01-01 3232
2011-04-01 3096
2011-07-01 3815
2011-10-01 3573
2012-01-01 3697
2012-04-01 3725
2012-07-01 4019
2012-10-01 3991
2013-01-01 3609
2013-04-01 3745
2013-07-01 3809
2013-10-01 3882
2014-01-01 3817
2014-04-01 3988
2014-07-01 4295
2014-10-01 4572
2015-01-01 4440
2015-04-01 4447
2015-07-01 4505
2015-10-01 4808
2016-01-01 4761
2016-04-01 4837
2016-07-01 5349
2016-10-01 5588
2017-01-01 5680
2017-04-01 5851
2017-07-01 5298
2017-10-01 5242
2018-01-01 5264
2018-04-01 5737
2018-07-01 5795
2018-10-01 5949
2019-01-01 5850
2019-04-01 5771
2019-07-01 5735
2019-10-01 5241
2020-01-01 5446
2020-04-01 5406
2020-07-01 5384
2020-10-01 5484
2021-01-01 5310
2021-04-01 5269
2021-07-01 5385
2021-10-01 5512
2022-01-01 5363
2022-04-01 5290
2022-07-01 5839
2022-10-01 5981
2023-01-01 5964
2023-04-01 6614
2023-07-01 7238
2023-10-01 7594
2024-01-01 7326
2024-04-01 8257

Subscribe to the FRED newsletter


Follow us

Back to Top